NCT00257322View on ClinicalTrials.gov

Cellular Immune Augmentation in Colon and Rectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Colon CancerRectal Cancer
Interventions
DRUG

GM-CSF

250ug/m\^2 SQ QD with a cap of 500mcg SQ QD

Trial Locations (1)

92868

Chao Family Comprehensive Cancer Center, Orange

All Listed Sponsors
lead

University of California, Irvine

OTHER

NCT00257322 - Cellular Immune Augmentation in Colon and Rectal Cancer | Biotech Hunter | Biotech Hunter